Virax Biolabs Group Ltd. (VRAX)
1.99
-0.12
(-5.69%)
USD |
NASDAQ |
Oct 08, 11:55
Virax Biolabs Group Market Cap : 1.153M for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 1.222M |
| October 06, 2026 | 1.176M |
| October 05, 2026 | 1.390M |
| October 02, 2026 | 1.274M |
| October 01, 2026 | 1.297M |
| September 30, 2026 | 1.265M |
| September 29, 2026 | 1.292M |
| September 28, 2026 | 1.340M |
| September 25, 2026 | 1.387M |
| September 24, 2026 | 1.413M |
| September 23, 2026 | 1.477M |
| September 22, 2026 | 1.448M |
| September 21, 2026 | 1.338M |
| September 18, 2026 | 1.471M |
| September 17, 2026 | 1.465M |
| September 16, 2026 | 1.442M |
| September 15, 2026 | 1.500M |
| September 14, 2026 | 1.512M |
| September 11, 2026 | 1.546M |
| September 10, 2026 | 1.651M |
| September 09, 2026 | 1.581M |
| September 08, 2026 | 1.523M |
| September 04, 2026 | 1.520M |
| September 03, 2026 | 1.483M |
| September 02, 2026 | 1.474M |
| Date | Value |
|---|---|
| September 01, 2026 | 1.506M |
| August 31, 2026 | 1.633M |
| August 28, 2026 | 1.633M |
| August 27, 2026 | 1.703M |
| August 26, 2026 | 1.604M |
| August 25, 2026 | 1.686M |
| August 24, 2026 | 1.738M |
| August 21, 2026 | 1.848M |
| August 20, 2026 | 1.998M |
| August 19, 2026 | 1.842M |
| August 18, 2026 | 1.599M |
| August 17, 2026 | 1.628M |
| August 14, 2026 | 1.656M |
| August 13, 2026 | 1.633M |
| August 12, 2026 | 1.610M |
| August 11, 2026 | 1.662M |
| August 10, 2026 | 1.668M |
| August 07, 2026 | 1.726M |
| August 06, 2026 | 1.604M |
| August 05, 2026 | 1.686M |
| August 04, 2026 | 1.726M |
| August 03, 2026 | 1.703M |
| July 31, 2026 | 1.518M |
| July 30, 2026 | 1.622M |
| July 29, 2026 | 1.697M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Interpace Biosciences, Inc. | 33.24M |
| Akso Health Group | 956.53M |
| AstraZeneca PLC | 486.65B |
| GSK Plc | 92.77B |
| PD-Rx Pharmaceuticals, Inc. | 5.099M |
Market Cap Related Metrics
| PS Ratio | 61.76 |
| PEG Ratio | -0.0003 |
| Price | 1.99 |
| Earnings Yield | -849.8% |
| PEGY Ratio | -0.0003 |